Mk-7145 Medchemexpress

MK-7145

HY-18277 Get quote Ask for price
Description: MK-7145 is a ROMK inhibitor, with an IC50 of 0.045 μM.

Human IgG antibody Laboratories manufactures the mk-7145 medchemexpress reagents distributed by Genprice. The Mk-7145 Medchemexpress reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact MedChemExpress Inc.. Other Mk-7145 products are available in stock. Specificity: Mk-7145 Category: Medchemexpress

MK-7145

50mg Ask for price
Description: MK-7145

MK-7145

5mg Ask for price
Description: MK-7145

True Blue

5.0mg
EUR 595

True Blue

5(mg
EUR 635

True Blue

5x5(mg
EUR 2705

True Blue

10mg Ask for price
Description: True Blue

True Blue

1g Ask for price
Description: True Blue

Chemicals information

MK-447

HY-100297 10mg
EUR 2047.2
Description: MK-447 is a free radical scavenger, also a nonsteroidal antiinflammatory agent, and enhances the formation of the endoperoxide, PGH2, and other prostaglandins.

MK-6913

HY-100327 10mg
EUR 7346.4
Description: MK-6913 (Tetrahydrofluoroene 52) is a potent and selective estrogen receptor β agonist.

MK-8617

HY-101023 50mg
EUR 443.73
Description: MK-8617 is an orally active pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) with an IC50 of 1 nM for PHD2.

MK-6240

HY-101186 50mg
EUR 3847.2

MK-212

HY-101324 Get quote Ask for price
Description: MK-212 (CPP) is a centrally acting 5-HT1C/5-HT2 agonist. MK-212 can stimulate phosphoinositide hydrolysis in cerebral cortex[1].

MK-4541

HY-125065 Get quote Ask for price
Description: MK-4541 is an orally active and selective androgen receptor (AR) modulator. MK-4541 acts as an antagonist to inhibit 5α-reductase. MK-4541 inhibits proliferation and induces apoptosis in AR positive prostate cancer cells. MK-4541 significantly inhibited the growth of R3327-G prostate tumors in xenograft mouse model[1].

MK-4101

HY-100036 100mg
EUR 411.26
Description: MK-4101 is a Smoothened (SMO) antagonist (IC50 of 1.1 µM for 293 cells ) and also a potent inhibitor of the hedgehog pathway (IC50 of 1.5 µM for mouse cells; IC50 of 1 µM for KYSE180 oesophageal cancer cells). MK-4101 has robust antitumor activity that inhibits tumor cell proliferation and induces extensive apoptosis[1].

MK-0249

HY-U00076 5mg
EUR 2745.6

MK 0893

HY-50663 10mM/1mL
EUR 1850.68
Description: MK 0893 is a potent and selective glucagon receptor antagonist with an IC50 of 6.6 nM.

MK-0812

HY-50669 5mg
EUR 194.81
Description: MK-0812 is a potent and selective CCR2 antagonist with low nM affinity for CCR2.

MK-0731

HY-50672 Get quote Ask for price
Description: MK-0731 is a selective, non-competitive and allosteric kinesin spindle protein (KSP) inhibitor with an IC50 of 2.2 nM and a pKa of 7.6. MK-0731 is >20,000 fold selectivity against other kinesins. MK-0731 induces mitotic arrest and induces apoptosis in tumors. MK-0731 provides significant antitumor efficacy[1][2].

MK-2461

HY-50703 50mg
EUR 1369.07

MK-1903

HY-107581 10 mg
EUR 919.93
Description: MK-1903 is a potent and selective hydroxycarboxylic acid receptor 2 (HCA2, GPR109A) full agonist[1].

MK-4074

HY-107709 10mM/1mL
EUR 1298.72
Description: MK-4074 is a liver-specific inhibitor of acetyl-CoA carboxylase ACC1 and ACC2 with IC50 values of approximately 3 nM.

MK-3903

HY-107988 10mM/1mL
EUR 487.02
Description: MK-3903 is a potent and selective AMP-activated protein kinase (AMPK) activator with an EC50 of 8 nM.

MK-2206

HY-108232 Get quote Ask for price
Description: MK-2206 is an orally active, highly potent and selective allosteric Akt inhibitor, with IC50s of 8, 12, and 65 nM for Akt1, Akt2, and Akt3, respectively. Many breast cancer cell lines, and PIK3CA-mutant and cell lines with PTEN loss are sensitive to MK-2206. MK-2206 has anticancer activities[1][2].

MK-0752

HY-10974 100mg
EUR 970.79
Description: MK-0752 is a potent, orally active and specific γ-secretase inhibitor, showing dose-dependent reduction of Aβ40 with an IC50 of 5 nM in human SH-SY5Y cells. MK-0752 crosses the blood-brain barrier. MK-0752 reduces newly generated CNS Aβ in vivo[1][2].